Ohio Study Shows Access To Naloxone Soars Without Rx Requirement
You may also be interested in...
Development of the model DFLs was a first for agency, reflecting alarm over public health crisis of overdoses from opioid abuse, which reached nearly 48,000 in 2017. The project was "part of our broader commitment to addressing the opioid crisis" and should help sponsors with potential naloxone OTC switch NDAs, says Commissioner Scott Gottlieb.
Proclaiming the opioid epidemic a public health emergency, President points to FDA's prescriber training requirements and withdrawal of Opana ER; Sen. Leahy decries lack of additional funding.